This year, the EPA will begin to implement the Endocrine Disruptor Screening Program (EDSP), which was established in 1998. Initially, 67 pesticide active ingredients and high-production volume chemicals used as pesticide inert ingredients will be screened. Tier 1 of the EDSP will screen the substances for interactions with estrogen, androgen or thyroid hormone systems. Substances […]
Appeals US federal appeals courts have ruled on two long running patent infringement cases involving Applied Biosystems and Waters. Last fall, the US District Court of Appeals for the Federal Circuit ruled on appeals brought by Cohesive Technologies (now Thermo Fisher Scientific) and Waters related to Cohesive’s 1998 suit against Waters (see IBO 12/15/98). In […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
